Cargando…

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy

PURPOSE: Intravitreal anti-VEGF injection (IVI) is administered before vitrectomy to assist management of proliferative diabetic retinopathy (PDR)-related complications. In the clinical setting, retinal surgeons determine the use of preoperative IVI based on individual criteria. In this study, we in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takayama, Kei, Someya, Hideaki, Yokoyama, Hiroshi, Kimura, Takeshi, Takamura, Yoshihiro, Morioka, Masakazu, Terasaki, Hiroto, Ueda, Tetsuo, Ogata, Nahoko, Kitano, Shigehiko, Tashiro, Maki, Sakamoto, Taiji, Takeuchi, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500446/ https://www.ncbi.nlm.nih.gov/pubmed/34624063 http://dx.doi.org/10.1371/journal.pone.0258415

Ejemplares similares

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019)

Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study
por: Takayama, Kei, et al.
Publicado: (2019)

Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy
por: Takamura, Yoshihiro, et al.
Publicado: (2018)

Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
por: Morioka, Masakazu, et al.
Publicado: (2020)

Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema
por: Takamura, Yoshihiro, et al.
Publicado: (2023)

Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
por: Yamashita, Mariko, et al.
Publicado: (2014)

Comparison of the intraocular pressure following an intravitreal triamcinolone acetonide injection for diabetic macula oedema in vitrectomised and non-vitrectomised eyes
por: Orii, Yusuke, et al.
Publicado: (2021)

Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
por: Yamada, Yutaka, et al.
Publicado: (2022)

The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen
por: Takamura, Yoshihiro, et al.
Publicado: (2021)

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012)

Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration
por: Yamashita, Mariko, et al.
Publicado: (2018)

Association between Systemic Factors and Vitreous Fluid Cytokines in Proliferative Diabetic Retinopathy
por: Sato, Tomohito, et al.
Publicado: (2023)

Selective Gene Transfer to the Retina Using Intravitreal Ultrasound Irradiation
por: Sonoda, Shozo, et al.
Publicado: (2012)

Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients
por: Izuta, Hiroshi, et al.
Publicado: (2009)

Impact of Intravitreal Anti-VEGF Therapy on Microperimetry of the Retinal Nonperfusion Areas of Patients with Proliferative Diabetic Retinopathy
por: Parravano, Mariacristina, et al.
Publicado: (2022)

VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals
por: Yamakuchi, Munekazu, et al.
Publicado: (2023)

Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
por: Oshima, Hideyuki, et al.
Publicado: (2022)

Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
por: Nguyen, Quan Dong, et al.
Publicado: (2023)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
por: Takayama, Kei, et al.
Publicado: (2012)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan
por: Maeda, Yuki, et al.
Publicado: (2019)

Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan
por: Sugimoto, Masahiko, et al.
Publicado: (2018)

Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
por: Yasuda, Mami, et al.
Publicado: (2017)

Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy
por: Zhang, Yunda, et al.
Publicado: (2021)

Vitreous hemorrhage in diabetes patients with proliferative diabetic retinopathy undergoing hemodialysis
por: Kameda, Yusuke, et al.
Publicado: (2019)

Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
por: Sato, Tomohito, et al.
Publicado: (2018)

En-Face Optical Coherence Tomography Is Useful for Assessing Striated Lesions in Angioid Streaks: A Case Report
por: Takeuchi, Takashi, et al.
Publicado: (2023)

Renal function after intravitreal administration of vascular endothelial growth factor inhibitors in patients with diabetes and chronic kidney disease
por: Kameda, Yusuke, et al.
Publicado: (2018)

Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
por: Shimura, Masahiko, et al.
Publicado: (2023)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
por: Tsubota, Kinya, et al.
Publicado: (2019)

Effect of intravitreal or sub-tenon triamcinolone acetonide injection at completion of vitrectomy on peripheral retinochoroidal thickness in eyes with proliferative diabetic retinopathy
por: Fujiwara, Yoshito, et al.
Publicado: (2019)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

The remote effects of intravitreal anti-VEGF therapy
por: Balta, F, et al.
Publicado: (2016)

Issues with Intravitreal Administration of Anti-VEGF Drugs
por: Schargus, Marc, et al.
Publicado: (2020)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
por: Cox, Jacob T., et al.
Publicado: (2021)

Shorter Axial Length Is a Risk Factor for Proliferative Vitreoretinopathy Grade C in Eyes Unmodified by Surgical Invasion
por: Minami, Sakiko, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes in 314 Japanese Patients with Bacterial Endophthalmitis: A Multicenter Cohort Study from J-CREST
por: Ishikawa, Hiroto, et al.
Publicado: (2021)

Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
por: Kameda, Yusuke, et al.
Publicado: (2021)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nj7cei65a3eb017v90k3h6ts3l